Loading…
Intralesional Cidofovir in the Treatment of Cutaneous Warts in a Renal Transplant Patient
Background: Cutaneous warts are often recalcitrant to conventional therapy in immunocompromised patients. Cidofovir is a potent antiviral agent shown to have a broad spectrum of action against DNA virus, including human papillomavirus. Objective: To determine the efficacy of intralesional cidofovir...
Saved in:
Published in: | Journal of cutaneous medicine and surgery 2012-11, Vol.16 (6), p.462-464 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background:
Cutaneous warts are often recalcitrant to conventional therapy in immunocompromised patients. Cidofovir is a potent antiviral agent shown to have a broad spectrum of action against DNA virus, including human papillomavirus.
Objective:
To determine the efficacy of intralesional cidofovir in the treatment of florid warts in an immunocompromised renal transplant patient.
Method:
The patient received seven injections of intralesional cidofovir at 4 week intervals in his numerous palmar warts.
Conclusion:
Based on our results, intralesional cidofovir is a promising therapeutic modality in the treatment of cutaneous warts in the renal transplant population.
Contexte:
Les verrues cutanées se montrent souvent réfractaires au traitement habituel chez les immunodéficients. Le cidofovir est un antiviral puissant, doté d'un large spectre d'action contre les virus à ADN, y compris contre le papillomavirus humain.
Objectif:
L'étude visait à déterminer l'efficacité du cidofovir intralésionnel dans le traitement de verrues florides chez un patient immunodéprimé, ayant subi une transplantation rénale.
Méthode:
Le patient a reçu sept injections de cidofovir intralésionnel, à 4 semaines d'intervalle, dans les nombreuses verrues palmaires.
Conclusion:
D'après les résultats obtenus, le cidofovir intralésionnel serait porteur d'avenir dans le traitement des verrues cutanées chez les patients ayant subi une transplantation rénale. |
---|---|
ISSN: | 1203-4754 1615-7109 |
DOI: | 10.1177/120347541201600622 |